Octopus Biosafety SA (OCR) Financial Statements
Octopus Biosafety SA Financial Overview
Octopus Biosafety SA's market cap is currently $19.45M. The company's EPS TTM is ―; its P/E ratio is -3.48; Octopus Biosafety SA has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 52.31K | $ 229.35K | $ 21.80K | $ 66.82K | $ 223.34K |
| Gross Profit | $ -336.29K | $ -69.95K | $ -55.13K | $ -1.10M | $ -1.37M |
| Operating Income | $ -837.48K | $ -1.44M | $ -735.27K | $ -1.14M | $ -1.40M |
| EBITDA | $ -453.69K | $ -1.19M | $ -482.40K | $ -753.90K | $ -576.26K |
| Net Income | $ -659.11K | $ -1.78M | $ -802.73K | $ -1.01M | $ -831.98K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 22.87K | $ 125.87K | $ 56.61K | $ 78.52K | $ 689.63K |
| Total Assets | $ 489.46K | $ 770.92K | $ 1.63M | $ 1.70M | $ 2.22M |
| Total Debt | $ 546.84K | $ 353.37K | $ 538.14K | $ 1.72M | $ 466.22K |
| Net Debt | $ 523.97K | $ 227.50K | $ 481.53K | $ 685.56K | $ -455.29K |
| Total Liabilities | $ 1.15M | $ 767.78K | $ 3.07M | $ 2.33M | $ 1.85M |
| Stockholders' Equity | $ -655.97K | $ 3.14K | $ -1.44M | $ -635.85K | $ 374.73K |
| Cash Flow | |||||
| Free Cash Flow | $ 0.00 | $ 0.00 | $ 487.08K | $ 988.54K | $ 954.19K |
| Operating Cash Flow | $ 0.00 | $ 0.00 | $ 487.08K | $ 988.54K | $ 954.19K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
Currency in EUR
